Findings

What do systematic reviews say?

6 questions · 6 findings · 1 reviews · Schizophrenia

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1 · 16.7%GRADE not reported 0 · 0%Very low 4 · 66.7%Low 1 · 16.7%Moderate 0 · 0%High 0 · 0%

Closest answers

The findings closest to your search, judged one by one by TypeSafe's Jev model.

Direct match · question page
- CHOLINERGIC DRUGS vs PLACEBO · Tardive dyskinesia: No clinically important improvement
  Cholinergic medication for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
  RR 0.89 [0.65, 1.23]
  4 studies · 27 participants
  Very low
Direct match · question page
- CHOLINERGIC DRUGS vs PLACEBO · Adverse effects: Any adverse events
  Cholinergic medication for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
  RR 0.56 [0.15, 2.14]
  4 studies · 106 participants
  Very low
Direct match · question page
- CHOLINERGIC DRUGS vs PLACEBO · Tardive dyskinesia: Deterioration
  Cholinergic medication for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
  RR 1.11 [0.55, 2.24]
  8 studies · 147 participants
  Low
Direct match · question page
- CHOLINERGIC DRUGS vs PLACEBO · Acceptability of treatment: Leaving the study early
  Cholinergic medication for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
  RR 1.09 [0.56, 2.1]
  12 studies · 288 participants
  Very low
Direct match · question page
- CHOLINERGIC DRUGS vs PLACEBO · Mental state: Deterioration
  Cholinergic medication for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
  RR 0.5 [0.1, 2.61]
  5 studies · 77 participants
  Very low

CHOLINERGIC DRUGS vs placebo

Tardive dyskinesia: No clinically important improvement · patients with antipsychotic‐induced tardive dyskinesia

It is very uncertain whether CHOLINERGIC DRUGS changes tardive dyskinesia: No clinically important improvement compared with PLACEBO (very low certainty).

1 finding from 1 review

Cholinergic medication for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
RR 0.89 [0.65, 1.23]
4 studies · 27 participants
Very low

CHOLINERGIC DRUGS vs placebo

Tardive dyskinesia: Deterioration of symptoms · patients with antipsychotic‐induced tardive dyskinesia

CHOLINERGIC DRUGS showed no clear difference in tardive dyskinesia: Deterioration compared with PLACEBO (low certainty).

1 finding from 1 review

Cholinergic medication for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
RR 1.11 [0.55, 2.24]
8 studies · 147 participants
Low

CHOLINERGIC DRUGS vs placebo

General mental state: Deterioration · patients with antipsychotic‐induced tardive dyskinesia

It is very uncertain whether CHOLINERGIC DRUGS changes mental state: Deterioration compared with PLACEBO (very low certainty).

1 finding from 1 review

Cholinergic medication for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
RR 0.5 [0.1, 2.61]
5 studies · 77 participants
Very low

CHOLINERGIC DRUGS vs placebo

Adverse effects: Any adverse events · patients with antipsychotic‐induced tardive dyskinesia

It is very uncertain whether CHOLINERGIC DRUGS changes adverse effects: Any adverse events compared with PLACEBO (very low certainty).

1 finding from 1 review

Cholinergic medication for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
RR 0.56 [0.15, 2.14]
4 studies · 106 participants
Very low

CHOLINERGIC DRUGS vs placebo

Secondary outcome: acceptability of treatment · patients with antipsychotic‐induced tardive dyskinesia

It is very uncertain whether CHOLINERGIC DRUGS changes acceptability of treatment: Leaving the study early compared with PLACEBO (very low certainty).

1 finding from 1 review

Cholinergic medication for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
RR 1.09 [0.56, 2.1]
12 studies · 288 participants
Very low

CHOLINERGIC DRUGS vs placebo

Social confidence, social inclusion, social networks, or personalised quality of life ‐ not reported · patients with antipsychotic‐induced tardive dyskinesia

The review found no eligible studies for this question.

1 finding from 1 review

Cholinergic medication for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found